中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
MiR-125b targets BCL3 and suppresses ovarian cancer proliferation

文献类型:期刊论文

作者Guan, Yi ; Yao, Hailan ; Zheng, Zhihong ; Qiu, Guangrong ; Sun, Kailai
刊名INTERNATIONAL JOURNAL OF CANCER
出版日期2011
卷号128期号:10页码:2274-2283
关键词miR-125b ovarian cancer proliferation BCL3 MICRORNA EXPRESSION PROFILES CELL-PROLIFERATION SURVIVAL STIMULATION MALIGNANCY RESISTANCE APOPTOSIS ROLES
ISSN号0020-7136
通讯作者Sun, KL (reprint author), China Med Univ, Dept Med Genet, Shenyang 110001, Peoples R China,klsun@mail.cmu.edu.cn
英文摘要Micro-RNAs (miRNAs) important for post-transcriptional gene expression as negative regulators are endogenous 21- to 23-nucleotide noncoding RNAs. Many miRNAs are expressed in ovarian cancer (OC). In this study, we reported that miR-125b was underexpressed in human OC specimens. Ectopic expression of miR-125b in OC cells induced cell cycle arrest and led to reduction in proliferation and clonal formation. This inhibitory effect on OC cell growth was mediated by miR-125b inhibition of the translation of an mRNA encoding a proto-oncogene, BCL3. Furthermore, expression of miR-125b suppressed the tumor formation generated by injecting OC cells in nude mice. Our results suggest that aberrantly expressed miR-125b may contribute to OC development.
学科主题Oncology
收录类别SCI
资助信息NNSF of China[30571836]
语种英语
公开日期2012-07-13
源URL[http://ir.sibs.ac.cn/handle/331001/1541]  
专题上海神经科学研究所_神经所(总)
推荐引用方式
GB/T 7714
Guan, Yi,Yao, Hailan,Zheng, Zhihong,et al. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation[J]. INTERNATIONAL JOURNAL OF CANCER,2011,128(10):2274-2283.
APA Guan, Yi,Yao, Hailan,Zheng, Zhihong,Qiu, Guangrong,&Sun, Kailai.(2011).MiR-125b targets BCL3 and suppresses ovarian cancer proliferation.INTERNATIONAL JOURNAL OF CANCER,128(10),2274-2283.
MLA Guan, Yi,et al."MiR-125b targets BCL3 and suppresses ovarian cancer proliferation".INTERNATIONAL JOURNAL OF CANCER 128.10(2011):2274-2283.

入库方式: OAI收割

来源:上海神经科学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。